CioteronelAlternative Names: CPC 10997; Cyoctol; X-Andron
Latest Information Update: 31 Aug 2007
At a glance
- Originator Chantal Pharmaceuticals
- Class Antiacnes; Antineoplastics; Hormones
- Mechanism of Action Testosterone congener inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Acne; Alopecia; Benign prostatic hyperplasia; Keloids; Mycoses